Aditxt (ADTX) Stock Surges 49% on Clinical Trial Proposalby Lilu Anderson 08.08.2024Aditxt (ADTX) stock is soaring after a major update on a clinical trial for early ovarian cancer detection, driving heavy ...
SoundThinking Q2 2024: Strong Growth with ShotSpotter Expansionby Mark Eisenberg 07.08.2024SoundThinking reports a robust 22% revenue increase in Q2 2024, driven by ShotSpotter expansion and strategic partnerships.
Constellation Energy Boosts Earnings Guidance, Confident in Buybacksby Mark Eisenberg 07.08.2024Constellation Energy raises full-year earnings guidance and continues robust share buyback program, marking strong financial performance.
PAHO and IDB Launch AI Readiness Toolkit for Public Healthby Lilu Anderson 07.08.2024Discover how PAHO and IDB are helping countries integrate AI into public health with their new readiness assessment toolkit.
Jumia Reports Mixed Q2 Results Amid Market Challengesby Mark Eisenberg 07.08.2024Jumia's Q2 2024 shows growth in orders by 6.9% but revenue declines 17.2% due to currency devaluation challenges.
BlackRock Files With SEC for Ethereum ETF Optionsby John Darbie 07.08.2024BlackRock seeks SEC approval for Ethereum ETF options, aiming to enhance investor access to ETH. Decision expected by April 2025.
Exploring China’s XR Ecosystem: A Journey Through Key Citiesby Lilu Anderson 07.08.2024Join us as we explore China's XR ecosystem from August 29 to September 23, visiting Guangzhou, Shenzhen, Hangzhou, Qingdao, and ...
Roche Considers Divesting $1.9 Billion Cancer Data Startupby Mark Eisenberg 07.08.2024Roche is evaluating options for its $1.9 billion investment in Flatiron Health, potentially including divestment.
Bitcoin Nears $57K; Solana and Toncoin Surge in Mixed Crypto Marketby John Darbie 07.08.2024Bitcoin climbed 1.8% to $56,829, while Solana surged 7% to $151. Mixed trends observed with some tokens rising and others ...
Stifel Lowers Celsius Holdings Target to $61, Maintains Buy Ratingby Mark Eisenberg 07.08.2024Stifel revises Celsius Holdings' price target to $61, citing future sales adjustments and increased spending. Buy rating maintained.